Author Archives: Darlene Huang

05.15.19

A tale of two sentiments two weeks after FDA permits the sale of IQOS

By | Leave a Comment

It’s been just over two weeks since the U.S. Food and Drug Administration (FDA) authorized the sale of Philip Morris’ IQOS heated tobacco product (HTP) system in regular tobacco and menthol flavors. It’s also been exactly two years since the premarket tobacco product application (PMTA) for this product that creates an aerosol (not smoke) from […]

Posted in FDA, Food and Drug Law, Non-Communicable Diseases, Tobacco ; Tagged: , , .

04.04.19

Reflecting on progress made in tobacco and nicotine products regulation under FDA Commissioner Gottlieb

By | Leave a Comment

Tomorrow is Commissioner Gottlieb’s last day on the job at the U.S. Food and Drug Administration (FDA), and he’s been treating these last few days much like he has his entire two-year tenure: with carefully thought out and coordinated communication about both in-process and potential future FDA actions. While the agency has been hard at […]

Posted in FDA, Food and Drug Law, Non-Communicable Diseases, Tobacco ; Tagged: , , , .

02.11.19

Reality check: Cigarettes are the only reason reduced risk tobacco products are even a thing

By | Leave a Comment

First, a confession. I’m a total public health nerd. I’ve been absolutely captivated by the prevention of disease at a population level since I was introduced to the concept late in college. From the science that drives it to the programs, policies, and laws that either embrace or hinder it and everything in between and […]

Posted in FDA, Food and Drug Law, Non-Communicable Diseases, Tobacco ; Tagged: , , , , .

01.25.19

Develop your skills blending law, science, and policy as a Tobacco Regulatory Science Fellow at the U.S. Food and Drug Administration

By | Leave a Comment

At my high school graduation, a friend and I had a short dialogue speaking to our graduating class about where our futures were headed. “What do you want to be when you grow up?” I asked her. She confidently answered, “A horse.” After an awkward moment or two went by, she continued with, “Or at […]

Posted in FDA, Food and Drug Law, Non-Communicable Diseases, Tobacco ; Tagged: , , .

12.11.18

Furthering Tobacco Control Requires a Broader Perspective

By | Leave a Comment

Tobacco control efforts in the U.S. have predominantly been a state, local, and increasingly tribal endeavor with landmark federal reports and legislation spurring or guiding local actions. When I started in tobacco control at the local level in 2006, the CDC’s Best Practices for Comprehensive Tobacco Control Programs was our roadmap. It focused our efforts […]

Posted in FDA, Food and Drug Law, Non-Communicable Diseases, Tobacco ; Tagged: , , , , , .

Stay Informed

Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute

Or sign up for our RSS Feed

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.